CUSIP 04280A100 · who reports it, how much, and how much it matters to them
37 of the 720 hedge fund managers we track reported shares of Arrowhead Pharmaceuticals, Inc. (Nasdaq: ARWR) on Form 13F for 30 June 2026. Between them they reported USD 1.6bn. The largest position belongs to Avoro Capital Advisors, at USD 926m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Avoro Capital Advisors1 fund on PPLI.com | USD 926m | 8.3% |
| 2 | Baker Bros. Advisors2 funds on PPLI.com | USD 162m | 0.8% |
| 3 | Holocene Advisors2 funds on PPLI.com | USD 90m | 0.2% |
| 4 | Summit Partners Public Asset Management14 funds on PPLI.com | USD 68m | 1.2% |
| 5 | Two Sigma Investments35 funds on PPLI.com | USD 47m | 0.0% |
| 6 | Balyasny Asset Management25 funds on PPLI.com | USD 38m | 0.0% |
| 7 | Renaissance Technologies13 funds on PPLI.com | USD 38m | 0.1% |
| 8 | D. E. Shaw & Co.15 funds on PPLI.com | USD 35m | 0.0% |
| 9 | Millennium Management6 funds on PPLI.com | USD 27m | 0.0% |
| 10 | Artisan Partners1 fund on PPLI.com | USD 25m | 0.0% |
| 11 | Marshall Wace LLP84 funds on PPLI.com | USD 25m | 0.0% |
| 12 | Squarepoint Ops7 funds on PPLI.com | USD 21m | 0.0% |
| 13 | Weiss Asset Management5 funds on PPLI.com | USD 11m | 0.1% |
| 14 | PFM Health Sciences3 funds on PPLI.com | USD 11m | 0.9% |
| 15 | Platinum Investment Management11 funds on PPLI.com | USD 5.3m | 1.3% |
| 16 | Jain Global1 fund on PPLI.com | USD 5m | 0.0% |
| 17 | Brevan Howard Capital Management39 funds on PPLI.com | USD 4.8m | 0.0% |
| 18 | Cormorant Asset Management1 fund on PPLI.com | USD 4.1m | 0.2% |
| 19 | Boothbay Fund Management2 funds on PPLI.com | USD 3.4m | 0.0% |
| 20 | Edgestream Partners5 funds on PPLI.com | USD 3.2m | 0.1% |
| 21 | M28 Capital Management1 fund on PPLI.com | USD 3m | 6.4% |
| 22 | Polymer Capital Management (HK)1 fund on PPLI.com | USD 3m | 0.2% |
| 23 | Engineers Gate Manager1 fund on PPLI.com | USD 3m | 0.0% |
| 24 | Exome Asset Management2 funds on PPLI.com | USD 2.6m | 1.6% |
| 25 | Landscape Capital Management4 funds on PPLI.com | USD 2.1m | 0.1% |
| 26 | Hudson Bay Capital Management8 funds on PPLI.com | USD 2.1m | 0.0% |
| 27 | LMR Partners2 funds on PPLI.com | USD 1.6m | 0.0% |
| 28 | Voleon Capital Management13 funds on PPLI.com | USD 1.5m | 0.0% |
| 29 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 749,000 | 0.0% |
| 30 | Diametric Capital2 funds on PPLI.com | USD 694,000 | 0.1% |
| 31 | Dark Forest Capital Management2 funds on PPLI.com | USD 679,000 | 0.0% |
| 32 | Lighthouse Investment Partners190 funds on PPLI.com | USD 611,000 | 0.0% |
| 33 | Ivyrock Asset Management (HK)1 fund on PPLI.com | USD 571,000 | 0.3% |
| 34 | CIBC Asset Management69 funds on PPLI.com | USD 353,000 | 0.0% |
| 35 | Bayforest Capital1 fund on PPLI.com | USD 270,000 | 0.2% |
| 36 | Persistent Asset Partners10 funds on PPLI.com | USD 39,288 | 0.0% |
| 37 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 10,304 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Avoro Capital Advisors | USD 926m | 8.3% |
| 2 | M28 Capital Management | USD 3m | 6.4% |
| 3 | Exome Asset Management | USD 2.6m | 1.6% |
| 4 | Platinum Investment Management | USD 5.3m | 1.3% |
| 5 | Summit Partners Public Asset Management | USD 68m | 1.2% |
| 6 | PFM Health Sciences | USD 11m | 0.9% |
| 7 | Baker Bros. Advisors | USD 162m | 0.8% |
| 8 | Ivyrock Asset Management (HK) | USD 571,000 | 0.3% |
| 9 | Bayforest Capital | USD 270,000 | 0.2% |
| 10 | Cormorant Asset Management | USD 4.1m | 0.2% |
Arrowhead Pharmaceuticals, Inc. trades under the symbol ARWR on the Nasdaq. Its CUSIP, the code used on Form 13F, is 04280A100.
37 of the 720 hedge fund managers PPLI.com tracks reported Arrowhead Pharmaceuticals, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Avoro Capital Advisors (USD 926m), Baker Bros. Advisors (USD 162m), Holocene Advisors (USD 90m), Summit Partners Public Asset Management (USD 68m) and Two Sigma Investments (USD 47m).
37 managers in our coverage reported it, and between them they run 616 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Avoro Capital Advisors, where the position was 8.3% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Arrowhead Pharmaceuticals, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.